MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 203 filers reported holding MYRIAD GENETICS INC in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,181,400 | +35.9% | 180,000 | -15.1% | 2.32% | +48.5% |
| Q4 2022 | $3,076,120 | -13.3% | 212,000 | +14.0% | 1.56% | +20.1% |
| Q3 2022 | $3,549,000 | -11.6% | 186,000 | -15.8% | 1.30% | -19.0% |
| Q2 2022 | $4,016,000 | +38.9% | 221,000 | +92.7% | 1.61% | +66.0% |
| Q1 2022 | $2,891,000 | -44.9% | 114,710 | -39.6% | 0.97% | -33.1% |
| Q4 2021 | $5,244,000 | +2.8% | 190,000 | +20.3% | 1.45% | +8.1% |
| Q3 2021 | $5,102,000 | -2.6% | 158,000 | -7.7% | 1.34% | +10.1% |
| Q2 2021 | $5,237,000 | +0.1% | 171,242 | -0.3% | 1.22% | -16.3% |
| Q1 2021 | $5,231,000 | +21.0% | 171,785 | -21.4% | 1.45% | -10.0% |
| Q4 2020 | $4,324,000 | – | 218,650 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |